Suchergebnisse - "Nieboer, Daan"

PubPharm (12)

1

Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

enthalten in: European urology open science | 2022

von Remmers, S. | Helleman, J. | Nieboer, D. | +94

2

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment : Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium

enthalten in: European urology open science | 2022

von Olivier, J. | Li, W. | Nieboer, D. | +91

CommentIn: J Urol. 2022 Nov;208(5):1159-1161. - PMID 35984095

3

Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

enthalten in: European urology open science | 2021

von Beckmann, K. | Santaolalla, A. | Helleman, J. | +86

4

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer : Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative

enthalten in: European urology oncology | 2020

von Kalapara, A. | Verbeek, J. | Nieboer, D. | +91

CommentIn: Eur Urol Oncol. 2020 Feb;3(1):92-93. - PMID 31839586

5

Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer : External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

enthalten in: European urology | 2019

von Drost, F. | Nieboer, D. | Morgan, T. | +78

6

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative : A Prerequisite for Future Studies

enthalten in: European urology oncology | 2019

von van der Kwast, T. | Helleman, J. | Nieboer, D. | +77

7

Personalized schedules for surveillance of low-risk prostate cancer patients

enthalten in: Biometrics | 2019

von Tomer, A. | Nieboer, D. | Roobol, M. | +2

8

Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

enthalten in: European urology | 2019

von Van Hemelrijck, M. | Ji, X. | Helleman, J. | +92

CommentIn: J Urol. 2020 Feb;203(2):252-253. - PMID 31710568

9

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer

enthalten in: World journal of urology | 2016

von Venderbos, L. | Roobol, M. | Bangma, C. | +7

10

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer

enthalten in: World journal of urology | 2015

von Venderbos, L. | Roobol, M. | Bangma, C. | +7